Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virtual Reality for Pain and Anxiety in Hematology Care
NCT03483194Phase 3Completed
- Sponsor
- Weprom
- Start
- Sep 2018
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial, sponsored by Weprom. Primary endpoint: Assessment of pain at 15 months. Started Sep 2018; status: completed.
Beyond the preview
Go deeper on NCT03483194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483194.